跳至主要内容
临床试验/EUCTR2012-003544-68-IT
EUCTR2012-003544-68-IT进行中(未招募)不适用

Randomized cross-over study of patient preference for oral or intravenous vinorelbine in the treatment of advanced NSCLC. A phase IV study. - VIVOS

ISTITUTO SCIENTIFICO ROMAGNOLO PER LO STUDIO E LA CURA DEI TUMORI0 个研究点开始时间: 2012年10月11日最近更新:

试验速览

阶段
不适用
状态
进行中(未招募)

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional clinical trial of medicinal product

入排标准

性别
All

入选标准

  • Patients affected by stage IIIB or stage IV NSCLC candidates to receive a first line chemotherapy with vinorelbine due to age = 70 and Eastern Cooperative Oncology Group (ECOG) Performance status =2 or age = 70 but ECOG PS = 2
  • Are the trial subjects under 18? no
  • Number of subjects for this age range: 0
  • F.1.2 Adults (18-64 years) yes
  • F.1.2.1 Number of subjects for this age range 50
  • F.1.3 Elderly (>=65 years) yes
  • F.1.3.1 Number of subjects for this age range 70

排除标准

  • 1. Patients who have had previous chemotherapy for lung cancer or radiotherapy on target lesions.
  • 2. Participation in another clinical trial with any investigational agents within 30 days prior to study screening.
  • 3. Presence of infection.
  • 4. Preexisting clinically significant peripheral neuropathy.

研究者

相似试验